63 related articles for article (PubMed ID: 11871470)
1. Trypanasome coat provides potential for new drugs.
Sansum C
Lancet Infect Dis; 2001 Sep; 1(2):70. PubMed ID: 11871470
[No Abstract] [Full Text] [Related]
2. Glycosyl phosphatidylinositols in Trypanosoma brucei.
Raper J; Doering TL; Buxbaum LU; Englund PT
Exp Parasitol; 1993 Mar; 76(2):216-20. PubMed ID: 8454032
[No Abstract] [Full Text] [Related]
3. Chemical validation of GPI biosynthesis as a drug target against African sleeping sickness.
Smith TK; Crossman A; Brimacombe JS; Ferguson MA
EMBO J; 2004 Nov; 23(23):4701-8. PubMed ID: 15526036
[TBL] [Abstract][Full Text] [Related]
4. Designing sleeping sickness control.
Kinoshita T
ACS Chem Biol; 2008 Oct; 3(10):601-3. PubMed ID: 18928247
[TBL] [Abstract][Full Text] [Related]
5. Discovery of trypanocidal compounds by whole cell HTS of Trypanosoma brucei.
Mackey ZB; Baca AM; Mallari JP; Apsel B; Shelat A; Hansell EJ; Chiang PK; Wolff B; Guy KR; Williams J; McKerrow JH
Chem Biol Drug Des; 2006 May; 67(5):355-63. PubMed ID: 16784460
[TBL] [Abstract][Full Text] [Related]
6. An assay for screening drugs against animal-infective bloodstream forms of Trypanosoma brucei brucei in vitro.
Borowy NK; Hirumi H; Waithaka HK; Mkoji G
Drugs Exp Clin Res; 1985; 11(3):155-61. PubMed ID: 3836123
[TBL] [Abstract][Full Text] [Related]
7. Combined contribution of TbAT1 and TbMRPA to drug resistance in Trypanosoma brucei.
Lüscher A; Nerima B; Mäser P
Mol Biochem Parasitol; 2006 Dec; 150(2):364-6. PubMed ID: 16935360
[No Abstract] [Full Text] [Related]
8. Antitrypanosomal alkaloids from Polyalthia suaveolens (Annonaceae): their effects on three selected glycolytic enzymes of Trypanosoma brucei.
Ngantchou I; Nyasse B; Denier C; Blonski C; Hannaert V; Schneider B
Bioorg Med Chem Lett; 2010 Jun; 20(12):3495-8. PubMed ID: 20529682
[TBL] [Abstract][Full Text] [Related]
9. In vitro trypanocidal activity of the anti-helminthic drug niclosamide.
Merschjohann K; Steverding D
Exp Parasitol; 2008 Apr; 118(4):637-40. PubMed ID: 18226810
[TBL] [Abstract][Full Text] [Related]
10. [Rational concepts and the study of active molecules against various trypanosomiases].
Périé J; de Albuquerque C; Blonski C; Chauvière G; Gefflaut T; Page P; Trinquier M; Willson M
Bull Soc Pathol Exot; 1994; 87(5):353-61. PubMed ID: 7496200
[TBL] [Abstract][Full Text] [Related]
11. Trypanocidal activity of a new series of arsenical compounds the spiroarsorans.
Loiseau P; Bories C; Gayral P; Wolf JG
Farmaco Sci; 1988; 43(7-8):657-63. PubMed ID: 3224710
[TBL] [Abstract][Full Text] [Related]
12. Trypanocidal effects of gallic acid and related compounds.
Koide T; Nose M; Inoue M; Ogihara Y; Yabu Y; Ohta N
Planta Med; 1998 Feb; 64(1):27-30. PubMed ID: 9491765
[TBL] [Abstract][Full Text] [Related]
13. In vitro effect of alkaloids on bloodstream forms of Trypanosoma brucei and T. congolense.
Merschjohann K; Sporer F; Steverding D; Wink M
Planta Med; 2001 Oct; 67(7):623-7. PubMed ID: 11582539
[TBL] [Abstract][Full Text] [Related]
14. Trypanocidal activity of bergenin, the major constituent of Flueggea virosa, on Trypanosoma brucei.
Nyasse B; Nono J; Sonke B; Denier C; Fontaine C
Pharmazie; 2004 Jun; 59(6):492-4. PubMed ID: 15248469
[TBL] [Abstract][Full Text] [Related]
15. The effect of trypanocidal drugs on the transmission of Trypanosoma brucei brucei by Glossina morsitans centralis.
Jefferies D; Jenni L
Acta Trop; 1987 Mar; 44(1):23-8. PubMed ID: 2884836
[TBL] [Abstract][Full Text] [Related]
16. Trypanosoma brucei: expression of multiple purine transporters prevents the development of allopurinol resistance.
Natto MJ; Wallace LJ; Candlish D; Al-Salabi MI; Coutts SE; de Koning HP
Exp Parasitol; 2005 Feb; 109(2):80-6. PubMed ID: 15687014
[TBL] [Abstract][Full Text] [Related]
17. Antiproliferative effect of dihydroxyacetone on Trypanosoma brucei bloodstream forms: cell cycle progression, subcellular alterations, and cell death.
Uzcátegui NL; Carmona-Gutiérrez D; Denninger V; Schoenfeld C; Lang F; Figarella K; Duszenko M
Antimicrob Agents Chemother; 2007 Nov; 51(11):3960-8. PubMed ID: 17682096
[TBL] [Abstract][Full Text] [Related]
18. [GPI biosynthetic pathway as a target for antiprotozoan drugs].
Nagamune K; Kinoshita T
Tanpakushitsu Kakusan Koso; 2002 Jan; 47(1):30-6. PubMed ID: 11808192
[No Abstract] [Full Text] [Related]
19. Effect of in vitro cultivation on the stability of resistance of Trypanosoma brucei brucei to diminazene, isometamidium, quinapyramine, and Mel B.
Kaminsky R; Zweygarth E
J Parasitol; 1989 Feb; 75(1):42-5. PubMed ID: 2918443
[TBL] [Abstract][Full Text] [Related]
20. Development of antitrypanosomal and antiplasmodial nonpeptidic cysteine protease inhibitors based on N-protected-guanidino-furan and -pyrrole building blocks.
Langolf S; Machon U; Ehlers M; Sicking W; Schirmeister T; Büchhold C; Gelhaus C; Rosenthal PJ; Schmuck C
ChemMedChem; 2011 Sep; 6(9):1581-6. PubMed ID: 21678556
[No Abstract] [Full Text] [Related]
[Next] [New Search]
